Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
1992-8-25
|
| pubmed:abstractText |
To determine whether the 50% dose reduction of all chemotherapeutic agents recommended for babies (less than or equal to 12 months of age) by the Third National Wilms' Tumor Study (NWTS-3) produced acceptable toxicity without sacrificing any survival benefit.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0732-183X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
10
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1305-9
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:1321894-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:1321894-Child, Preschool,
pubmed-meshheading:1321894-Humans,
pubmed-meshheading:1321894-Infant,
pubmed-meshheading:1321894-Kidney Neoplasms,
pubmed-meshheading:1321894-Life Tables,
pubmed-meshheading:1321894-Survival Analysis,
pubmed-meshheading:1321894-Treatment Outcome,
pubmed-meshheading:1321894-Wilms Tumor
|
| pubmed:year |
1992
|
| pubmed:articleTitle |
Outcomes in low-risk babies treated with half-dose chemotherapy according to the Third National Wilms' Tumor Study.
|
| pubmed:affiliation |
Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia 19104.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|